Abstract The phosphanegold(I) thiocarbamides, Ph 3 PAu{SC(OR)=NC 6 H 4 Me-4} for R = Me (1), Et (2) and iPr (3), have been shown to have essentially linear gold atom coordination geometries defined by phosphane-P and thiolate-S atoms, and exhibit minimum inhibitory concentration (MIC) values in the range of 1-37 μg/ml against four Gram-positive bacteria, namely Bacillus cereus, Enterococcus faecalis, Enterococcus faecium and Staphylococcus aureus; compounds 1-3 are less potent against a broad panel of 16 Gram-negative bacteria. As the minimum bactericidal concentration values were quite similar to the MIC values, compounds 1-3 are effective bactericidal agents. The specific action against the four Gram-positive bacteria suggests they function by inhibition of peptidoglycan synthesis.
Introduction
It is now widely recognised that the increase in bacterial resistance, the rapid emergence of new infections, and even overprescription of antibiotics have significantly decreased the efficacy of drugs employed in the treatment of pathologies instigated by certain microorganisms [1, 2] . Infections caused by Gram-positive organisms are of major concern due to the increased incidence and the high level of multidrug resistance [3, 4] . Increasing resistance in both enterococci (lactic acid bacteria) and staphylococci (skincolonising bacteria) [5] has accelerated the need for the development of new antimicrobial agents to treat these Gram-positive infections [6] . Herein, the specific antimicrobial activity against four Gram-positive bacteria exhibited by a series of gold compounds is described.
Disease-modifying antirheumatic drugs based on gold are well established in the treatment of rheumatoid arthritis [7, 8] . Gold(I) compounds used in this context range from charged, polymeric and water-soluble gold(I) thiolates such as sodium gold(I) thiomalate (Myocrisin®) and the neutral, monomeric and lipophilic phosphanegold(I) thiolate, triethylphosphanegold(I) tetraacetylthioglucose (Auranofin®) [9, 10] . While research continues in developing new antirheumatic agents and in understanding the mechanism of action [11] [12] [13] [14] , much recent attention has focussed upon investigating the anticancer potential of gold(I) and, especially, gold(III) compounds [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] . Other ailments/diseases, too, have been investigated such as anti-viral (HIV AIDS), anti-asthma (acute corticosteroid) and even tropical diseases, e.g. malaria and Chagas disease [13, 14] . Attention has also been directed towards antimicrobial activity, the focus of the present report.
A range of synthetic gold compounds shown strong inhibitory and antimicrobial effects. Exploiting the antiinflammatory activity of Auranofin® as well as its ability to inhibit thiol-based redox enzymes renders this an exciting prospect for the development of novel antimicrobial agents [24] . The majority of research in this area has in fact focussed upon analogues of Auranofin®, i.e. phosphanegold(I) thiolates [24] [25] [26] [27] , but with attention also being directed to the study of N-heterocyclic carbene [28] , thiolate [29] and carboxylate [30, 31] derivatives. Relatively less consideration has been devoted to gold(III) species [32] . In the present study, phosphanegold(I) thiolates 1-3 ( Fig. 1) will be shown to display marked biological activities. Specifically, 1-3 exhibit selective and antimicrobial activities against four Grampositive bacteria suggesting that these may be potentially developed as alternative bactericidal agents. All chemicals and solvents were sourced commercially and used as received. All reactions were carried out under ambient conditions. The thiocarbamides, ROC(=S)N(H)C 6 H 4 Me-4 for R=Me, Et and iPr, were prepared in quantitative yields as d e s c r i b e d i n t h e l i t e r a t u r e [3 3 ] . F o r e x a m p l e , MeOC(=S)N(H)C 6 H 4 Me-4 was prepared from the stoichiometric reaction of S=C=NC 6 H 4 Me-4 and MeOH in the presence of equimolar NaOH with MeOH serving as the solvent.
Experimental

General
T h e p h o s p h a n e g o l d ( I ) t h i o c a r b a m i d e s , Ph 3 PAu{SC(OR)=NC 6 H 4 Me-4} for R=Me, Et and iPr, were obtained from the reaction of Ph 3 PAuCl precursor (synthesised by the reduction of KAuCl 4 by sodium sulfite followed by addition of the stoichiometric amount of triphenylphosphane) with one mole equivalent of ROC(=S)N(H)C 6 H 4 Me-4 in the presence of NaOH, following standard procedures [34] . Details for the synthesis of 3 are given here; 1 and 2 were prepared in an analogous fashion. NaOH (0.5 mmol) in MeOH (5 mL) was added to a suspension of Ph 3 PAuCl (0.5 mmol) in MeOH (20 mL), followed by addition of iPrOC(=S)N(H)C 6 H 4 Me-4 in MeOH (20 mL 
X-ray crystallography
Intensity measurements for a colourless block (0.06×0.06× 0.11 mm) of 3 were made at 100 K on an Agilent Supernova dual diffractometer with an Atlas (Mo) detector (ω scan technique) using graphite monochromatized Mo Kα radiation [35] . The structure was solved by direct methods (SHELXS97 [36] through the WinGX Interface [37] ) and refined (anisotropic displacement parameters, H atoms in the riding model approximation and a final weighting scheme of the form . A view of the molecular structure is shown in Fig. 2 , drawn at the 50 % probability level with ORTEP-3 for Windows [37] , and the overlay diagram (Fig. 3) was drawn with QMol [38] . The crystal packing analysis was conducted with the aid of PLATON [39] and Fig. 4 was drawn with DIAMOND [40] .
Screening for antibacterial activity
Antibacterial screening was performed using the disc diffusion method in accordance with the National Committee for Clinical Laboratory Standards (NCCLS) guideline. A total of 20 bacterial strains were used in this study 8 CFU/ml) by adding Mueller-Hinton broth. This suspension was then swabbed on the surface of Mueller-Hinton agar plates using a sterile cotton swab. The tested compounds were dissolved in DMSO to the test concentration of 1 mg/ml. Sterile 6 mm filter paper discs were aseptically placed on Mueller-Hinton agar surfaces and 10 μl of the dissolved compounds were immediately added to discs. Each plate contained one standard antibiotic paper disc served as positive control, one disc served as negative control (10 μl broth) and one disc served as solvent control (10 μl DMSO). The plates were incubated at 37°C for 24 h. Antibacterial activity was evaluated by measuring the diameter of inhibition zone against the test bacterial strains. Each experiment was performed in duplicate.
Determination of minimum inhibitory concentration and minimum bactericidal concentration
The minimum inhibitory concentration (MIC) was determined by the broth microdilution method according to the NCCLS. The tested compounds were serially threefold diluted in DMSO to the test concentrations of 1,000, 330, 110, 37, 12, 4, 1 and 0.5 μg/ml and then placed into each well of a 96-well microplate. An inoculum suspension with density of 10 5 CFU/ml of exponentially growing bacterial cells was added into each well. The 96-well microplates were incubated at 37°C for 24 h. All tests were performed in triplicate. Four controls comprising medium with standard antibiotic (positive control), medium with DMSO (solvent control), medium with inoculum bacterial cells (negative control), and medium with broth only (negative growth control) were included in each test. Bacterial growth was detected by adding 50 μl of a 0.2 mg/ml p-iodonitrotetrazolium violet (INT) indicator solution into each of the microplate wells and incubated at 37°C for 30 min under aerobic agitation. Where bacterial growth was inhibited, the suspension in the well remained clear after incubation with INT. By contrast, the INT changed from clear to red in the presence of bacterial activity. The lowest concentration of the tested compound which completely inhibited bacterial growth was taken as the MIC. After MIC determination of each tested compound, an aliquot of 100 μl from each well which showed no visible growth was spread onto MHA at 37°C for 30 min. The minimum bactericidal concentration (MBC) was defined as the lowest concentration of the tested compound producing a 99.9 % reduction in bacterial viable count on the MHA.
Results and discussion
Synthesis and characterisation
Crystallography, NMR and theoretical studies confirm that the ROC(=S)N(H)C 6 H 4 Me-4 molecules exist as amides rather than thiols [33] . The Ph 3 PAu{SC(OR)=NC 6 H 4 Me-4}, for R=Me (1), Et (2) Infrared spectroscopy confirmed the absence of ν(N-H) in the spectra of 1-3. Compared to that observed for ROC(=S)N(H)C 6 H 4 Me-4, systematic shifts to lower, lower, and higher wavenumber are noted for absorptions due to ν(C-N), ν(C-O) and ν(C-S) in 1-3 consistent with the mode of complexation of the anions indicated in Fig. 1 . This is confirmed by a crystal structure determination of 3.
The molecular structure of 3 is illustrated in Fig. 2 . The gold atom is linearly coordinated by the phosphane-P1 and thiolate-S1 atoms with bond lengths of 2.2561(7) and 2.3171(7) Å, respectively. The C1-S1 and C1-N1 bond lengths of 1.776(3) and 1.269(4) Å, respectively, have significantly elongated and shortened compared to related "free" thiocarbamide molecules [33] , and are consistent with the notion that the molecule was deprotonated during the synthesis and coordinates as a thiolate. The P1-Au-S1 angle of 172.88(3)°deviates significantly from the ideal 180°and this feature is attributed to the close approach of the O1 atom to gold, i.e. Au…O1 is 2.887(2) Å.
Crystal structure determinations have been reported previously for each of 1 [41] and 2 [42] . As seen from the overlay diagram in Fig. 3 , a very similar mode of coordination is found for 1 and 3, which conforms to the norm for structures of this type [43] . However, a variation is noted in 2, where the arene ring is oriented towards the gold atom rather than the O1 atom; intra-and intermolecular Au…π(arene) interactions have been reviewed recently [44] . Such variations have been discussed in some detail in the literature and arise owing to the combination of subtle electronic and steric effects of the P-, Oand N-bound substituents [41] . Figure 4 illustrates the crystal packing in 3. Molecules associate into a three-dimensional architecture by a combination of edge-to-face C-H…π interactions, there being no other significant intermolecular interactions of note; see [45] for geometric parameters describing the intermolecular interactions. The interactions pivotally involve the p-tolyl ring in that it forms a donor interaction to a P-bound phenyl ring, and accepts two interactions from two P-bound phenyl rings.
Antimicrobial activity
The antibacterial activity of the gold compounds were determined against a wide variety of pathogens comprising four strains of Gram-positive bacteria and 16 strains of Gram-negative bacteria. The tested bacterial species vary with respect to their disease modality and virulence. Of the 20 tested bacterial species, only four bacterial species that belong to Gram-positive (B. cereus, E. faecalis, E. faecium and S. aureus) showed consistent inhibition zones towards 1-3 in disc diffusion assay; see data in Table 1 .
Briefly, no inhibitory activity was detected from 1 to 3 against any of the Gram-negative bacteria. The results revealed the specific effectiveness of the tested compound 1-3 on Gram-positive bacteria (which have thick peptidoglycan as the outermost layer in the cell wall), and not against Gram-negative bacteria (which have an outer membrane composed of phospholipids and lipopolysaccharide). As Gram-positive bacteria are dependent on peptidoglycan for their cell wall protection and to maintain osmotic pressure [46] , the mechanism for the antibacterial action of 1-3 might be related to the inhibition of peptidoglycan synthesis in the cell walls of Gram-positive bacteria leading to the death of the bacteria.
The serial dilution assay suggested that the inhibitory effects of 1-3 towards different pathogens in the disc diffusion assay were dose dependent. Table 2 collects the MIC and MBC values for the four Gram-positive pathogens in response to treatment with 1-3 and standard antibiotics. The MIC values were in the range of 1-37 μg/ml, which may be considered as high antibacterial activity in comparison with the standard antibiotic tetracycline for which the range in MIC values is 4-37 μg/ml. The most susceptible strains were B. cereus (1-4 μg/ml) and E. faecalis (4 μg/ml), while E. faecium (37 μg/ml) and S. aureus (37 μg/ml) showed the lowest sensitivity towards 1-3.
The MBC, time kill curve and serum bactericidal titre are the in vitro microbiological techniques uses to determine whether an antibacterial agent is bacteriostatic or bactericidal [47] . MBC was the method used in this study to determine the bactericidal activity of the tested compounds towards the inhibited pathogens. According to Levison [48] , antibacterial agents are regarded as bactericidal if the MBC is no more than fourfold higher than the MIC. By contrast, the MBC of bacteriostatic agents are many fold higher than their MIC. This is because the bacteriostatic agents only prevent the growth of bacteria, whereas bactericidal MIC minimum inhibitory concentration, MBC minimum bactericidal concentration, -bacteria grown across all tested dilution which showed bacteriostatic properties, ND not determined agents kill the bacteria [49] . The MBC values of 1-3 were same as their MIC, indicating good bactericidal effects against B. cereus, E. faecalis, E. faecium and S. aureus. Data from this study suggest that 1-3 could be potent against Bacillus spp., Staphylococcus spp. and Enterococcus spp., an observation in agreement with the recent report of Sordo et al. [31] , who found high antibacterial activity of certain gold sulfanylcarboxylates against Bacillus spp. and Staphylococcus spp. Previous reports suggested the potential importance of bactericidal drugs for treating bacterial infections in severely neutropenic patients, who exhibit abnormally low level of neutrophils in the blood and a lack of host defences to clear the infecting bacteria if bacteriostatic drugs are introduced [47, 48, 50] . In addition, it is noted that the Gram-positive bacteria are an important cause of infection in neutropenic patients [47, 51, 52] .
In summary, the easily synthesised, stable and crystalline gold compounds 1-3 may be potentially developed as alternative bactericidal agents for use in the treatment of microbial disease especially for recently emerging multidrugresistant strains of methicillin-resistant S. aureus (MRSA) [49] and Enterococcus spp. [53] which are known to cause life-threatening infections in humans. Efforts are underway to explore the antibacterial activities of related derivatives with variations in P-, O-, and N-substituents and into possible mechanisms of action.
